Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Male infertility can impact pregnancy chances more than many realise. An expert explains key causes, genetic factors, warning ...

In an interview with Jay Salazar from Panther Life Sciences, we discuss microarray patch (MAP) technology and its potential ...

A significant proportion of repeated pregnancy failures can be attributed to chromosomal abnormalities—either inherited from one of the parents or arising spontaneously in the embryo.

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Testing Market size is USD 2.24 Billion in 2025 and is expected to reach USD 6.66 Billion by 2035 due to the increasing adoption of NIPTAustin, March 10, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

U.S. Gene Expression Analysis Market size is USD 1.28 Billion in 2025 and is expected to reach USD 2.45 Billion by 2035 owing to high penetration of advanced molecular analysis technologies.Austin, ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.